Author Correction: Interleukin 17 signaling supports clinical benefit of dual CTLA-4 and PD-1 checkpoint inhibition in melanoma.
Renata VaraljaiLisa ZimmerYahya Al-MataryPaulien KapteinLea J AlbrechtBatool ShannanJan C BraseDaniel GusenleitnerTeresa AmaralNina WyssJochen UtikalLukas FlatzFlorian RambowHans Christian ReinhardtJenny DickDaniel R EngelSusanne HornSelma UgurelWiebke SondermannElisabeth LivingstoneAntje SuckerAnnette PaschenFang ZhaoJan M PlackeJasmin M KloseWolfgang P FendlerDaniela S ThommenIris HelfrichDirk SchadendorfAlexander RoeschPublished in: Nature cancer (2023)